EPCAM and non-small cell lung carcinoma: Ishizawa et al. reported the presence of CD45+EpCAM+ cells in both solid tumor tissues and malignant pleural effusions of patients with non-small cell lung cancer (NSCLC); it is highly suspected that cell population is involved in epithelial–mesenchymal transition (20).